K E Burdick1, M Russo1, S Frangou1, K Mahon1, R J Braga2, M Shanahan1, A K Malhotra2. 1. Departments of Psychiatry,Icahn School of Medicine at Mount Sinai,New York, NY,USA. 2. Zucker Hillside Hospital - North Shore Long Island Jewish Health System,Glen Oaks, NY,USA.
Abstract
BACKGROUND: Recent data suggest trait-like neurocognitive impairments in bipolar disorder (BPD), with deficits about 1 s.d. below average, less severe than deficits noted in schizophrenia. The frequency of significant impairment in BPD is approximately 60%, with 40% of patients characterized as cognitively spared. This contrasts with a more homogeneous presentation in schizophrenia. It is not understood why some BPD patients develop deficits while others do not. METHOD: A total of 136 patients with BPD completed the MATRICS Consensus Cognitive Battery and data were entered into hierarchical cluster analyses to: (1) determine the optimal number of clusters (subgroups) that fit the sample; and (2) assign subjects to a specific cluster based on individual profiles. We then compared subgroups on several clinical factors and real-world community functioning. RESULTS: Three distinct neurocognitive subgroups were found: (1) an intact group with performance comparable with healthy controls on all domains but with superior social cognition; (2) a selective impairment group with moderate deficits on processing speed, attention, verbal learning and social cognition and normal functioning in other domains; and (3) a global impairment group with severe deficits across all cognitive domains comparable with deficits in schizophrenia. CONCLUSIONS: These results suggest the presence of multiple cognitive subgroups in BPD with unique profiles and begin to address the relationships between these subgroups, several clinical factors and functional outcome. Next steps will include using these data to help guide future efforts to target these disabling symptoms with treatment.
BACKGROUND: Recent data suggest trait-like neurocognitive impairments in bipolar disorder (BPD), with deficits about 1 s.d. below average, less severe than deficits noted in schizophrenia. The frequency of significant impairment in BPD is approximately 60%, with 40% of patients characterized as cognitively spared. This contrasts with a more homogeneous presentation in schizophrenia. It is not understood why some BPD patients develop deficits while others do not. METHOD: A total of 136 patients with BPD completed the MATRICS Consensus Cognitive Battery and data were entered into hierarchical cluster analyses to: (1) determine the optimal number of clusters (subgroups) that fit the sample; and (2) assign subjects to a specific cluster based on individual profiles. We then compared subgroups on several clinical factors and real-world community functioning. RESULTS: Three distinct neurocognitive subgroups were found: (1) an intact group with performance comparable with healthy controls on all domains but with superior social cognition; (2) a selective impairment group with moderate deficits on processing speed, attention, verbal learning and social cognition and normal functioning in other domains; and (3) a global impairment group with severe deficits across all cognitive domains comparable with deficits in schizophrenia. CONCLUSIONS: These results suggest the presence of multiple cognitive subgroups in BPD with unique profiles and begin to address the relationships between these subgroups, several clinical factors and functional outcome. Next steps will include using these data to help guide future efforts to target these disabling symptoms with treatment.
Authors: David J Kupfer; Ellen Frank; Victoria J Grochocinski; Patricia A Cluss; Patricia R Houck; Debra A Stapf Journal: J Clin Psychiatry Date: 2002-02 Impact factor: 4.384
Authors: Lakshmi N Yatham; Ivan J Torres; Gin S Malhi; Sophia Frangou; David C Glahn; Carrie E Bearden; Katherine E Burdick; Anabel Martínez-Arán; Sandra Dittmann; Joseph F Goldberg; Aysegul Ozerdem; Omer Aydemir; K N Roy Chengappa Journal: Bipolar Disord Date: 2010-06 Impact factor: 6.744
Authors: Joseph Ventura; Gerhard S Hellemann; April D Thames; Vanessa Koellner; Keith H Nuechterlein Journal: Schizophr Res Date: 2009-07-22 Impact factor: 4.939
Authors: Abraham Reichenberg; Philip D Harvey; Christopher R Bowie; Ramin Mojtabai; Jonathan Rabinowitz; Robert K Heaton; Evelyn Bromet Journal: Schizophr Bull Date: 2008-05-20 Impact factor: 9.306
Authors: Paul Lichtenstein; Benjamin H Yip; Camilla Björk; Yudi Pawitan; Tyrone D Cannon; Patrick F Sullivan; Christina M Hultman Journal: Lancet Date: 2009-01-17 Impact factor: 79.321
Authors: Alison K Merikangas; Lihong Cui; Monica E Calkins; Tyler M Moore; Ruben C Gur; Raquel E Gur; Kathleen R Merikangas Journal: J Affect Disord Date: 2017-03-10 Impact factor: 4.839
Authors: Shanshan Zhu; Zachary A Cordner; Jiali Xiong; Chi-Tso Chiu; Arabiye Artola; Yanning Zuo; Andrew D Nelson; Tae-Yeon Kim; Natalya Zaika; Brian M Woolums; Evan J Hess; Xiaofang Wang; De-Maw Chuang; Mikhail M Pletnikov; Paul M Jenkins; Kellie L Tamashiro; Christopher A Ross Journal: Proc Natl Acad Sci U S A Date: 2017-09-11 Impact factor: 11.205
Authors: Katherine E Burdick; Caitlin E Millett; Manuela Russo; Martin Alda; Ney Alliey-Rodriguez; Amit Anand; Yokesh Balaraman; Wade Berrettini; Holli Bertram; Joseph R Calabrese; Cynthia Calkin; Carla Conroy; William Coryell; Anna DeModena; Scott Feeder; Carrie Fisher; Nicole Frazier; Mark Frye; Keming Gao; Julie Garnham; Elliot S Gershon; Kara Glazer; Fernando S Goes; Toyomi Goto; Gloria J Harrington; Petter Jakobsen; Masoud Kamali; Marisa Kelly; Susan Leckband; Else Marie Løberg; Falk W Lohoff; Adam X Maihofer; Michael J McCarthy; Melvin McInnis; Gunnar Morken; Caroline M Nievergelt; John Nurnberger; Ketil J Oedegaard; Abigail Ortiz; Megan Ritchey; Kelly Ryan; Martha Schinagle; Candice Schwebel; Martha Shaw; Paul Shilling; Claire Slaney; Emma Stapp; Bruce Tarwater; Peter Zandi; John R Kelsoe Journal: Neuropsychopharmacology Date: 2020-04-29 Impact factor: 7.853
Authors: Scott C Fears; Remmelt Schür; Rachel Sjouwerman; Susan K Service; Carmen Araya; Xinia Araya; Julio Bejarano; Emma Knowles; Juliana Gomez-Makhinson; Maria C Lopez; Ileana Aldana; Terri M Teshiba; Zvart Abaryan; Noor B Al-Sharif; Linda Navarro; Todd A Tishler; Lori Altshuler; George Bartzokis; Javier I Escobar; David C Glahn; Paul M Thompson; Carlos Lopez-Jaramillo; Gabriel Macaya; Julio Molina; Victor I Reus; Chiara Sabatti; Rita M Cantor; Nelson B Freimer; Carrie E Bearden Journal: Brain Date: 2015-05-05 Impact factor: 13.501
Authors: M Russo; T E Van Rheenen; M Shanahan; K Mahon; M M Perez-Rodriguez; A Cuesta-Diaz; E Larsen; A K Malhotra; K E Burdick Journal: Psychol Med Date: 2017-06-07 Impact factor: 7.723